Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PLAU | P00749 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5849366 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2A6MAPTMCL1BCL2L1 | |
| SCHEMBL24000175 | 0.87 | ALOX5 (0.36) | CYP1A2CYP2A6MAPTMCL1BCL2L1 | |
| SCHEMBL2391852 | 0.86 | ALDH1A1 (0.50) | CYP1A2CYP2A6MAPTMCL1BCL2L1 | |
| SCHEMBL30278835 | 0.85 | CYP1A2 (0.46) | CYP1A2CYP2A6MAPTALDH1A1L3MBTL1 | |
| SCHEMBL15639371 | 0.85 | CYP1A2 (0.46) | CYP1A2CYP2A6MAPTALDH1A1L3MBTL1 | |
| SCHEMBL18252668 | 0.84 | BCL2L1 (0.46) | CYP1A2CYP2A6MAPTMCL1BCL2L1 | |
| SCHEMBL15497379 | 0.84 | BCL2L1 (0.46) | CYP1A2CYP2A6MAPTMCL1BCL2L1 | |
| SCHEMBL22902217 | 0.83 | MAPT (0.53) | MAPTMCL1BCL2L1ALDH1A1L3MBTL1 | |
| SCHEMBL23280688 | 0.82 | ALDH1A1 (0.41) | CYP1A2MAPTMCL1BCL2L1ALDH1A1 | |
| SCHEMBL16273134 | 0.82 | MAPT (0.38) | CYP1A2MAPTMCL1BCL2L1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12510528-B2 | Method of determining hydrocarbon type in source rock samples | SAUDI ARABIAN OIL COMPANY (SA) | 2025-12-30 | — | — | US | disclosed |
| US-20230417728-A1 | METHOD OF DETERMINING HYDROCARBON TYPE IN SOURCE ROCK SAMPLES | ARAMCO SERVICES COMPANY (US) | 2023-12-28 | — | — | US | disclosed |
| CN-117250292-A | Separation and analysis method of heteroatom compounds in petroleum geological sample and application thereof | 中国石油天然气股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-113804535-B | Method and device for enriching C15-C32 molecular marker of wellhead dry gas | 中国石油大学(北京) | 2022-12-16 | — | — | CN | disclosed |
| CN-115073885-A | Fiber hybrid composite material and manufacturing method thereof | 浙江中纯新材料有限公司 | 2022-09-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12510528-B2 | Method of determining hydrocarbon type in source rock samples | BMP4, SRMS, TBK1 | CYP1A2 1074/4885CYP2A6 1744/4885MAPT 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.